Correlation of Gene Methylation in Surgical Margin Imprints with Locoregional Recurrence in Head and Neck Squamous Cell Carcinoma

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2015 Mar 17

PMID 25773145

Citations 20

Authors

Masamichi Hayashi

Gaosong Wu

Jong-Lyel Roh

Xiaofei Chang

Xiufeng Li

Julie Ahn

Marla Goldsmith

Zubair Khan

Justin Bishop

Zhe Zhang

Xian Chong Zhou

Jeremy Richmon

Nishant Agrawal

Wayne M Koch

Affiliations

Soon will be listed here.

Abstract

Background: Securing negative surgical margins is a critical goal for head and neck surgery. Local recurrence develops even in some patients who have histologically negative surgical margins. Minimal residual tumor cells may lead to locoregional recurrence despite clear histologic margins reported at the time of resection of head and neck squamous cell carcinoma (HNSCC). To identify subclinical residual disease, the authors analyzed deep margin imprint samples collected on 1-layer nitrocellulose sheets.

Methods: Bisulfite-treated DNA samples from 73 eligible patients were amplified by quantitative methylation-specific polymerase chain reaction (QMSP) targeting 6 genes (deleted in colorectal cancer [DCC], endothelin receptor type B [EDNRB], homeobox protein A9 [HOXA9], kinesin family member 1A [KIF1A], nidogen-2 [NID2], and N-methyl D-aspartate receptor subtype 2B [NR2B]). QMSP values were dichotomized as positive or negative. Associations between the QMSP status of deep margin samples and clinical outcomes were evaluated.

Results: Two-gene methylation combinations among the genes DCC, EDNRB, and HOXA9 were associated with decreased locoregional recurrence-free survival, recurrence-free survival, and overall survival. The methylated gene combination of EDNRB and HOXA9 in margin imprints was the most powerful predictor of poor locoregional recurrence-free survival (hazard ratio [HR], 3.31; 95% confidence interval [CI], 1.30-8.46; P = .012) independent of standard histologic factors. In addition, methylation of both EDNRB and HOXA9 indicated a trend toward reduced recurrence-free survival (HR, 2.74; 95% CI, 0.90-8.33; P = .075) and reduced OS (HR, 5.78; 95% CI, 0.75-44.7; P = .093) in multivariable analysis.

Conclusions: A panel of gene methylation targets in deep surgical margin imprints provides a potential predictive marker of postoperative locoregional recurrence. Intraoperative use of molecular margin imprint analysis may assist surgeons in obtaining rigorously negative surgical margins and improve the outcome of head and neck surgery.

Citing Articles

Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.

Hirai R, Kinugasa H, Yamamoto S, Ako S, Tsutsumi K, Abe M Br J Cancer. 2024; 130(10):1725-1731.

PMID: 38538728 PMC: 11091138. DOI: 10.1038/s41416-024-02654-2.

Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication-A Systematic Review.

Lee S, Leung K, Chung A, Wong E, Meehan K, Chan J Int J Mol Sci. 2022; 23(22).

PMID: 36430813 PMC: 9696529. DOI: 10.3390/ijms232214336.

High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.

Inokawa Y, Hayashi M, Begum S, Noordhuis M, Sidransky D, Califano J BMC Cancer. 2022; 22(1):1146.

PMID: 36344942 PMC: 9641857. DOI: 10.1186/s12885-022-10227-w.

Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis.

Camuzi D, de Almeida Simao T, Dias F, Pinto L, Soares-Lima S Cancers (Basel). 2021; 13(22).

PMID: 34830785 PMC: 8616074. DOI: 10.3390/cancers13225630.

Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy.

Sunagawa Y, Hayashi M, Yamada S, Tanabe H, Kurimoto K, Tanaka N Clin Epigenetics. 2021; 13(1):172.

PMID: 34530906 PMC: 8444591. DOI: 10.1186/s13148-021-01165-8.

References

Hayashi M, Guerrero-Preston R, Okamura J, Michailidi C, Kahn Z, Li X . Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer. Ann Surg Oncol. 2014; 21(9):3124-31. PMC: 4834866. DOI: 10.1245/s10434-014-3661-2. View

Schussel J, Zhou X, Zhang Z, Pattani K, Bermudez F, Jean-Charles G . EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res. 2013; 19(12):3268-75. PMC: 3687013. DOI: 10.1158/1078-0432.CCR-12-3496. View

Boyle J, Hakim J, Koch W, van der Riet P, Hruban R, Roa R . The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993; 53(19):4477-80. View

Demokan S, Dalay N . Role of DNA methylation in head and neck cancer. Clin Epigenetics. 2012; 2(2):123-50. PMC: 3365391. DOI: 10.1007/s13148-011-0045-3. View

Almangush A, Bello I, Keski-Santti H, Makinen L, Kauppila J, Pukkila M . Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 2013; 36(6):811-8. PMC: 4229066. DOI: 10.1002/hed.23380. View

Shaw R, Hobkirk A, Nikolaidis G, Woolgar J, Triantafyllou A, Brown J . Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. Ann Surg Oncol. 2012; 20(8):2796-802. DOI: 10.1245/s10434-012-2713-8. View

Iro H, Waldfahrer F . Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer. 1998; 83(10):2201-7. View

Koike M, Kodera Y, Itoh Y, Nakayama G, Fujiwara M, Hamajima N . Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol. 2008; 15(7):1977-82. DOI: 10.1245/s10434-008-9901-6. View

Kim Y, Yoon H, Kim J, Kang H, Min B, Kim S . HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int J Cancer. 2013; 133(5):1135-42. DOI: 10.1002/ijc.28121. View

10.

Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L . High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992; 7(6):1159-66. View

11.

Phe V, Cussenot O, Roupret M . Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int. 2009; 104(7):896-901. DOI: 10.1111/j.1464-410X.2009.08696.x. View

12.

Carvalho A, Chuang A, Jiang W, Lee J, Begum S, Poeta L . Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res. 2006; 66(19):9401-7. DOI: 10.1158/0008-5472.CAN-06-1073. View

13.

Jones A, Bin Hanafi Z, Nadapalan V, Roland N, Kinsella A, Helliwell T . Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996; 74(1):128-32. PMC: 2074609. DOI: 10.1038/bjc.1996.327. View

14.

Kim M, Yamashita K, Baek J, Park H, Carvalho A, Osada M . N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006; 66(7):3409-18. DOI: 10.1158/0008-5472.CAN-05-1608. View

15.

Harden S, Tokumaru Y, Westra W, Goodman S, Ahrendt S, Yang S . Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res. 2003; 9(4):1370-5. View

16.

Hwang S, Kim K, Kim J, Kim H, Lee M, Lee C . Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clin Chem Lab Med. 2011; 49(4):699-704. DOI: 10.1515/CCLM.2011.108. View

17.

Sun M, Song C, Huang H, Frankenberger C, Sankarasharma D, Gomes S . HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci U S A. 2013; 110(24):9920-5. PMC: 3683728. DOI: 10.1073/pnas.1305172110. View

18.

Huang X, Pateromichelakis S, Hills A, Sherriff M, Lyons A, Langdon J . p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res. 2007; 13(20):6099-106. DOI: 10.1158/1078-0432.CCR-07-1369. View

19.

Tao K, Wu C, Wu K, Li W, Han G, Shuai X . Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer. Med Oncol. 2011; 29(1):107-12. DOI: 10.1007/s12032-010-9805-8. View

20.

Beasley N, Prevo R, Banerji S, Leek R, Moore J, Van Trappen P . Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002; 62(5):1315-20. View